DrugPatentWatch Database Preview
Ciclesonide - Generic Drug Details
What are the generic sources for ciclesonide and what is the scope of ciclesonide patent protection?
Ciclesonide
is the generic ingredient in three branded drugs marketed by Astrazeneca Pharms and is included in three NDAs. There are seven patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Ciclesonide has two hundred patent family members in forty-five countries.
There are seven drug master file entries for ciclesonide. Two suppliers are listed for this compound.
Summary for ciclesonide
| International Patents: | 200 |
| US Patents: | 7 |
| Tradenames: | 3 |
| Applicants: | 1 |
| NDAs: | 3 |
| Drug Master File Entries: | 7 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 42 |
| Clinical Trials: | 67 |
| Patent Applications: | 5,600 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ciclesonide |
| DailyMed Link: | ciclesonide at DailyMed |
Synonyms for ciclesonide
| (11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione |
| (11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione |
| (11|A,16|A)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione |
| (R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate |
| 126544-47-6 |
| 141845-82-1 |
| 2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)- |
| 2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-CYCLOHEXYL-11-HYDROXY-9,13-DIMETHYL-16-OXO-5,7-DIOXAPENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOSA-14,17-DIEN-8-YL]-2-OXOETHYL 2-METHYLPROPANOATE |
| 2-oxoethyl isobutyrate |
| 2H-Naphth (2',1':4,5) indeno (1,2-d) (1,3) dioxole, pregna-1,4-diene-3,20-dione deriv. |
| 544C476 |
| AC-1330 |
| AKOS015994702 |
| Alvesco |
| Alvesco (TN) |
| Alvesco HFA |
| Alvesco, Ciclesonide |
| AN-15021 |
| B-9207-015 |
| BC220461 |
| BTR-15 |
| BTR-15K |
| BY-9010 |
| BYK-20426 |
| C-23151 |
| C32H44O7 |
| CAS-141845-82-1 |
| CC-25775 |
| CHEBI:31397 |
| CHEMBL2040682 |
| Ciclesonide (JAN/USAN/INN) |
| Ciclesonide [INN] |
| Ciclesonide [USAN:INN] |
| Ciclesonide, >=98% (HPLC) |
| Ciclesonide, European Pharmacopoeia (EP) Reference Standard |
| CS-2867 |
| D01703 |
| D0K7HU |
| DB01410 |
| DR003211 |
| DSSTox_CID_26659 |
| DSSTox_GSID_46659 |
| DSSTox_RID_81802 |
| DTXSID9046659 |
| el-87-6 |
| GTPL7469 |
| HY-B0625 |
| KS-1165 |
| LS-186047 |
| LUKZNWIVRBCLON-GXOBDPJESA-N |
| MolPort-005-940-705 |
| NCGC00167484-01 |
| NCGC00167972-01 |
| O945 |
| Omnair |
| Omnaris |
| Omnaris (TN) |
| Omnaris HFA |
| Omniair (TN) |
| Osonase |
| Osonide |
| PL018866 |
| Pregna-1,4-diene-3,20-dione, 16,17-(((R)-cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 16,17-((cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha(R))- |
| RPR 251526 |
| RPR-251526 |
| RPR251526 |
| s4646 |
| S59502J185 |
| SCHEMBL3688 |
| SR-01000942227 |
| SR-01000942227-1 |
| TBN-15 |
| Tox21_112486 |
| UNII-S59502J185 |
| Zetonna |
| ZINC3915154 |
US Patents and Regulatory Information for ciclesonide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharms | OMNARIS | ciclesonide | SPRAY, METERED;NASAL | 022004-001 | Oct 20, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Astrazeneca Pharms | OMNARIS | ciclesonide | SPRAY, METERED;NASAL | 022004-001 | Oct 20, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Astrazeneca Pharms | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-002 | Jan 10, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for ciclesonide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Astrazeneca Pharms | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-003 | Jan 10, 2008 | ➤ Sign Up | ➤ Sign Up |
| Astrazeneca Pharms | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-002 | Jan 10, 2008 | ➤ Sign Up | ➤ Sign Up |
| Astrazeneca Pharms | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-002 | Jan 10, 2008 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for ciclesonide
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Czech Republic | 9904604 | ➤ Sign Up |
| Eurasian Patent Organization | 200200375 | ➤ Sign Up |
| Slovakia | 6922002 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for ciclesonide
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2005006,C0983058 | Lithuania | ➤ Sign Up | PRODUCT NAME: CICLESONIDUM (11BETA,16ALFA)-16,17-(((R)-CIKLOHEKSILMETILEN)BIS(OKSI))-11-HIDROKSI-21-(2-METIL-1OKSOPROPOKSI)PREGNA-1,4-DIEN-3,20-DIONAS; REGISTRATION NO/DATE: LT/1/05/0181/001, LT/1/05/0181/002, LT/1/05/0181/003 20050321 |
| C022/2005 | Ireland | ➤ Sign Up | SPC022/2005, 20060612, EXPIRES: 20190415 |
| 2005 00036 | Denmark | ➤ Sign Up | |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
